Prudential plc’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $936K | Hold |
11,684
| – | – | 0.01% | 482 |
|
|
2025
Q4 | $996K | Hold |
11,684
| – | – | 0.01% | 470 |
|
|
2025
Q3 | $909K | Sell |
11,684
-108,022
| -90% | -$8.44M | 0.01% | 492 |
|
|
2025
Q2 | $9.36M | Sell |
119,706
-59,692
| -33% | -$4.45M | 0.06% | 178 |
|
|
2025
Q1 | $13M | Sell |
179,398
-33,971
| -16% | -$2.43M | 0.07% | 140 |
|
|
2024
Q4 | $15.8M | Buy |
213,369
+1,057
| +0.5% | +$74K | 0.08% | 109 |
|
|
2024
Q3 | $14M | Buy |
212,312
+56,277
| +36% | +$4.09M | 0.07% | 135 |
|
|
2024
Q2 | $14.4M | Buy |
156,035
+1,899
| +1% | +$168K | 0.1% | 120 |
|
|
2024
Q1 | $14.7M | Buy |
154,136
+85,810
| +126% | +$7.21M | 0.11% | 107 |
|
|
2023
Q4 | $5.21M | Buy |
68,326
+47,510
| +228% | +$3.31M | 0.05% | 230 |
|
|
2023
Q3 | $1.44M | Sell |
20,816
-20,635
| -50% | -$1.66M | 0.02% | 455 |
|
|
2023
Q2 | $3.91M | Sell |
41,451
-32,290
| -44% | -$2.81M | 0.05% | 257 |
|
|
2023
Q1 | $6.1M | Sell |
73,741
-2,957
| -4% | -$232K | 0.07% | 173 |
|
|
2022
Q4 | $5.72M | Buy |
76,698
+11,217
| +17% | +$865K | 0.07% | 187 |
|
|
2022
Q3 | $5.41M | Sell |
65,481
-2,117
| -3% | -$204K | 0.09% | 145 |
|
|
2022
Q2 | $6.43M | Sell |
67,598
-1,551
| -2% | -$161K | 0.12% | 121 |
|
|
2022
Q1 | $8.14M | Buy |
69,149
+17,509
| +34% | +$1.96M | 0.12% | 104 |
|
|
2021
Q4 | $6.69M | Buy |
51,640
+16,840
| +48% | +$1.96M | 0.09% | 97 |
|
|
2021
Q3 | $3.94M | Buy |
34,800
+14,340
| +70% | +$1.64M | 0.05% | 141 |
|
|
2021
Q2 | $2.12M | Buy |
20,460
+1,924
| +10% | +$181K | 0.02% | 287 |
|
|
2021
Q1 | $1.55M | Buy |
18,536
+872
| +5% | +$73.7K | 0.01% | 404 |
|
|
2020
Q4 | $1.61M | Sell |
17,664
-378
| -2% | -$31.4K | 0.01% | 398 |
|
|
2020
Q3 | $1.44M | Sell |
18,042
-1,191
| -6% | -$92.9K | 0.01% | 388 |
|
|
2020
Q2 | $1.33M | Buy |
+19,233
| New | +$1.37M | 0.01% | 377 |
|
|
2020
Q1 | – | Sell |
-7,383
| Closed | -$574K | – | 601 |
|
|
2019
Q4 | $574K | Sell |
7,383
-5,400
| -42% | -$422K | ﹤0.01% | 413 |
|
|
2019
Q3 | $937K | Buy |
12,783
+9,498
| +289% | +$667K | ﹤0.01% | 552 |
|
|
2019
Q2 | $203K | Hold |
3,285
| – | – | ﹤0.01% | 728 |
|
|
2019
Q1 | $210K | Buy |
+3,285
| New | +$187K | ﹤0.01% | 638 |
|
|
2018
Q3 | – | Sell |
-6,300
| Closed | -$306K | – | 726 |
|
|
2018
Q2 | $306K | Hold |
6,300
| – | – | ﹤0.01% | 636 |
|
|
2018
Q1 | $293K | Hold |
6,300
| – | – | ﹤0.01% | 638 |
|
|
2017
Q4 | $237K | Hold |
6,300
| – | – | ﹤0.01% | 668 |
|
|
2017
Q3 | $230K | Buy |
6,300
+273
| +5% | +$10.4K | ﹤0.01% | 652 |
|
|
2017
Q2 | $238K | Buy |
+6,027
| New | +$220K | ﹤0.01% | 646 |
|
|
2016
Q4 | – | Sell |
-6,243
| Closed | -$251K | – | 646 |
|
|
2016
Q3 | $251K | Hold |
6,243
| – | – | ﹤0.01% | 569 |
|
|
2016
Q2 | $208K | Buy |
+6,243
| New | +$214K | ﹤0.01% | 585 |
|
|
2016
Q1 | – | Sell |
-8,832
| Closed | -$233K | – | 605 |
|
|
2015
Q4 | $233K | Hold |
8,832
| – | – | ﹤0.01% | 555 |
|
|
2015
Q3 | $209K | Hold |
8,832
| – | – | ﹤0.01% | 500 |
|
|
2015
Q2 | $210K | Buy |
+8,832
| New | +$199K | ﹤0.01% | 517 |
|
Other funds holding EW
VCM
VPM
Prudential plc's EW Position: Q1 2026 in Review
Prudential plc held its Edwards Lifesciences (EW) position steady in Q1 2026 at 11,684 shares worth $936K. The position accounts for 0.01% of the portfolio, ranked #482.
Prudential plc first reported a position in EW in Q2 2015 and has held it in 38 quarters since. The position peaked at $15.8M in Q4 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Prudential plc held 11,684 shares of Edwards Lifesciences worth $936K as of Q1 2026.
- Prudential plc left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.01% of Prudential plc's portfolio in Q1 2026, its #482 holding.
- Prudential plc first reported a position in Edwards Lifesciences in Q2 2015 and has held it in 38 quarters since.
- Prudential plc's Edwards Lifesciences position peaked at $15.8M in Q4 2024.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Prudential plc's 13F filing for Q1 2026, filed 14 May 2026.